Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes
- PMID: 38758294
- PMCID: PMC11262049
- DOI: 10.2337/db23-0761
Increased Genetic Risk for β-Cell Failure Is Associated With β-Cell Function Decline in People With Prediabetes
Abstract
Partitioned polygenic scores (pPS) have been developed to capture pathophysiologic processes underlying type 2 diabetes (T2D). We investigated the association of T2D pPS with diabetes-related traits and T2D incidence in the Diabetes Prevention Program. We generated five T2D pPS (β-cell, proinsulin, liver/lipid, obesity, lipodystrophy) in 2,647 participants randomized to intensive lifestyle, metformin, or placebo arms. Associations were tested with general linear models and Cox regression with adjustment for age, sex, and principal components. Sensitivity analyses included adjustment for BMI. Higher β-cell pPS was associated with lower insulinogenic index and corrected insulin response at 1-year follow-up with adjustment for baseline measures (effect per pPS SD -0.04, P = 9.6 × 10-7, and -8.45 μU/mg, P = 5.6 × 10-6, respectively) and with increased diabetes incidence with adjustment for BMI at nominal significance (hazard ratio 1.10 per SD, P = 0.035). The liver/lipid pPS was associated with reduced 1-year baseline-adjusted triglyceride levels (effect per SD -4.37, P = 0.001). There was no significant interaction between T2D pPS and randomized groups. The remaining pPS were associated with baseline measures only. We conclude that despite interventions for diabetes prevention, participants with a high genetic burden of the β-cell cluster pPS had worsening in measures of β-cell function.
© 2024 by the American Diabetes Association.
Conflict of interest statement
Figures

References
-
- Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 2015;314:1021–1029 - PubMed
-
- Ligthart S, van Herpt TT, Leening MJ, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol 2016;4:44–51 - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK048434/DK/NIDDK NIH HHS/United States
- IK2-CX001907/US Department of Veterans Affairs
- K23DK114551/DK/NIDDK NIH HHS/United States
- R01 DK072041/DK/NIDDK NIH HHS/United States
- UG1 HD107691/HD/NICHD NIH HHS/United States
- NorthShore Auxiliary Scholars Award/NorthShore University HealthSystem
- U01 DK048468/DK/NIDDK NIH HHS/United States
- U01 DK048387/DK/NIDDK NIH HHS/United States
- 7-21-JDFM-005/American Diabetes Association
- U01 DK048407/DK/NIDDK NIH HHS/United States
- UG1 HD107691/NH/NIH HHS/United States
- U01 DK048437/DK/NIDDK NIH HHS/United States
- U01 DK048406/DK/NIDDK NIH HHS/United States
- UG1 HD107691/GF/NIH HHS/United States
- U01 DK048412/DK/NIDDK NIH HHS/United States
- P30 DK040561/DK/NIDDK NIH HHS/United States
- U01 DK048375/DK/NIDDK NIH HHS/United States
- U01 DK048413/DK/NIDDK NIH HHS/United States
- K23 DK114551/DK/NIDDK NIH HHS/United States
- U01 DK048397/DK/NIDDK NIH HHS/United States
- U01 DK048381/DK/NIDDK NIH HHS/United States
- U01 DK048339/DK/NIDDK NIH HHS/United States
- Webb Waring Biomedical Research Award/Boettcher Foundation
- IK2 CX001907/CX/CSRD VA/United States
- T32 DK007161/DK/NIDDK NIH HHS/United States
- U01 DK048514/DK/NIDDK NIH HHS/United States
- U01 DK048485/DK/NIDDK NIH HHS/United States
- U01 HG011723/HG/NHGRI NIH HHS/United States
- U01 DK048411/DK/NIDDK NIH HHS/United States
- U01 DK048443/DK/NIDDK NIH HHS/United States
- U01 DK048380/DK/NIDDK NIH HHS/United States
- U01 DK048400/DK/NIDDK NIH HHS/United States
- U01 DK048404/DK/NIDDK NIH HHS/United States
- K24 HL157960/HL/NHLBI NIH HHS/United States
- U01 DK048489/DK/NIDDK NIH HHS/United States
- U01 DK048349/DK/NIDDK NIH HHS/United States
- U01 DK048377/DK/NIDDK NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical